Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis
Wenlong Qi, Zhenyu Li, Jianan Xu, Tan Wang · 2025
Read Integration of circulating biomarkers and clinical factors: construction and validation of a prediction model for lung cancer metastasis by Wenlong Qi, Zhenyu Li, Jianan Xu, Tan Wang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12752214.txt.
Description
Wenlong Qi, Zhenyu Li, Jianan Xu, and Tan Wang build a prediction model for lung cancer metastasis from blood markers and clinical factors, in a research paper from 2025. Spread of lung cancer drives outcomes, so an early risk score can guide watch and treatment choices. Blood tests are cheap and routine, which makes them a practical base for such a score.
Data from more than five hundred patients treated between 2020 and 2024 split into training and validation sets. About two fifths of patients in each set had metastasis. Screening in the training set picked lymph node state, tumor size, and several blood markers as key factors. A nomogram model was built, checked for accuracy, and tested for clinical value.
Catalog record
| CREATOR | Wenlong Qi, Zhenyu Li, Jianan Xu, Tan Wang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |